|Last Update: 05/17/13 - 4:00 PM EDT|
|YTD Performance: -4.81%|
|Previous Close: $34.96|
|52 Week Range: $30.65 - $39.95|
|Oustanding Shares: 807,493,496|
|Market Cap: 20,696,598,421|
|Qtr (05/13)||Qtr (08/13)||FY (11/13)||FY (11/14)|
|Number of Analysts||7||7||13||13|
|Growth Rate (Year over Year)||-58.57%||5.32%||5.65%||30.83%|
CCL was downgraded from Buy to Neutral, Nomura said. $37.50 price target. Valuation call, as yield pricing remains soft.
Weakness in a company's business could mean poor earnings and reduced guidance.
Keep an eye on all three of these for an entry, but hold off buying until the technicals say so.
CCL earnings estimates were reduced, said Credit Suisse. Rising costs related to Triumph and limited visibility will impact earnings. Price target is $34.
CCL earnings estimates were reduced through 2014, said UBS. Europe demand is incrementally weaker since December, and Triumph impacted bookings. Price target is $38.
After the stock's news-based slide, we may see a reflexive reversal. Here's your technical setup.
CCL estimates were reduced through 2014, Credit Suisse said. Voyage disruptions should hurt results. Neutral rating.
CCL estimates were cut through 2014, Citigroup said. Company offered conservative guidance. Buy rating and $44 price target.
Shares of CCL downgraded to Hold from Buy, Jefferies said. $37 price target. Valuation call.